ClinicalTrials.govpublic full text
Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction
acute myocardial infarction (ami), gastrointestinal bleeding, percutaneous coronary intervention, dual antiplatelet therapy, potassium competitive acid blocker, zastaprazan, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847887
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.